Pediatric Liver Disease
The Pediatric Center for Liver Disease and Transplantation at NewYork-Presbyterian/Columbia University Medical Center cares for children with a wide range of liver diseases. Some conditions can be treated with medication, while others involve interventional procedures or surgery. Our expert multidisciplinary team is prepared to manage any liver disease that may affect your child and your family.
Conditions we treat that may require transplantation include:
- acute liver failure
- Alagille syndrome
- alpha 1 antitrypsin deficiency
- biliary atresia
- liver disease
- liver injury
- liver tumor
- neonatal hepatitis
- portal hypertension
- portal vein thrombosis
- variceal bleeding
- Wilson's disease
The care of children and adolescents with liver disease can be a lengthy and challenging process. Care at the Center for Liver Disease and Transplantation is delivered by a well-integrated team of gastrointestinal specialists devoted entirely to the care of children with liver diseases. Ours is the only transplant program with three board-certified pediatric gastrointestinal transplant specialists.
As a medical-surgical service, our surgeons and hepatologists are readily available to answer any parent and patient concerns. Nutritionists and physicians work closely together to formulate a plan to optimize the management of nutritional disorders affecting our patients, and our staff has in-depth knowledge and experience with the management of tube feedings and intravenous nutrition for children who require the most aggressive nutrition support. The Center also includes a social worker, nurse practitioners, and a financial assistant who helps families with insurance.
Services are provided at the Morgan Stanley Children's Hospital of Columbia University Medical Center – one of the nation’s leading centers for pediatric care, medical education, and scientific research – and at our satellite facility in Short Hills, New Jersey. NewYork-Presbyterian/Columbia is one of only five centers in the United States accredited to train Pediatric Transplant Hepatology Fellows.
Our pediatric patients have access to clinical trials that address the latest therapies in immunosuppression, including novel adult therapies that may be appropriate for older teenagers.